Q1 FY27 results: Revenue up 37%, PAT up 37%; Rs 600 cr fundraise approved
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neogen Chemicals Q1 FY27 standalone revenue rose 36.7% YoY to Rs 252.28 cr, PAT up 36.6% at Rs 19.44 cr. Consolidated revenue Rs 250.29 cr, PAT Rs 17.11 cr. Board approved Rs 600 cr fundraise via QIP or other modes, Integrated Report FY26, 37th AGM on Aug 21, and new internal auditor CNK & Associates. Crisil downgraded ratings to A2 and A-/Negative, pushing NCD coupon to 11%. Dahej fire insurance claim of Rs 186.63 cr still pending.
Strong Q1 growth and Rs 600 cr fundraise plan are positives. Rating downgrade and pending Dahej fire insurance claim are concerns.